Cargando…
A FinnGen pilot clinical recall study for Alzheimer’s disease
Successful development of novel therapies requires that clinical trials are conducted in patient cohorts with the highest benefit-to-risk ratio. Population-based biobanks with comprehensive health and genetic data from large numbers of individuals hold promise to facilitate identification of trial p...
Autores principales: | Julkunen, Valtteri, Schwarz, Claudia, Kalapudas, Juho, Hallikainen, Merja, Piironen, Aino-Kaisa, Mannermaa, Arto, Kujala, Hanna, Laitinen, Timo, Kosma, Veli-Matti, Paajanen, Teemu I., Kälviäinen, Reetta, Hiltunen, Mikko, Herukka, Sanna-Kaisa, Kärkkäinen, Sari, Kokkola, Tarja, Urjansson, Mia, Perola, Markus, Palotie, Aarno, Vuoksimaa, Eero, Runz, Heiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400697/ https://www.ncbi.nlm.nih.gov/pubmed/37537264 http://dx.doi.org/10.1038/s41598-023-39835-7 |
Ejemplares similares
-
FinnGen provides genetic insights from a well-phenotyped isolated population
por: Kurki, Mitja I., et al.
Publicado: (2023) -
TWINGEN – protocol for an observational clinical biobank recall and biomarker study to identify individuals with high risk of Alzheimer’s disease
por: Vuoksimaa, Eero, et al.
Publicado: (2023) -
Author Correction: FinnGen provides genetic insights from a well-phenotyped isolated population
por: Kurki, Mitja I., et al.
Publicado: (2023) -
Recontacting biobank participants to collect lifestyle, behavioural and cognitive information via online questionnaires: lessons from a pilot study within FinnGen
por: Rodosthenous, Rodosthenis S, et al.
Publicado: (2022) -
Increasing accuracy of HLA imputation by a population-specific reference panel in a FinnGen biobank cohort
por: Ritari, Jarmo, et al.
Publicado: (2020)